TET2 and Alzheimer disease: In the hippocampus of aged transgenic AD mice, a considerable decline in 5hmC and Tet2 levels was observed, which correlated with marked Aβ plaque accumulation, GFAP-positive astrogliosis, Iba1-positive microglia overgrowth, and the overproduction of pro-inflammatory factors.